ORMP ORAMED PHARMACEUTICALS INC Expansion Plans 8-K Filing 2024 - Clinical Trial Agreement Oramed Pharmaceuticals' subsidiary, Oramed Ltd., signed a $11.5 million agreement with InClin, Inc. for clinical research services related to a Phase 3 trial involving 300 type 2 diabetic patients.Get access to all SEC 8-K filings of the ORAMED PHARMACEUTICALS INC